Retinal Vein Occlusion clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

    “We hope to learn more about the safety and feasibility of using your own (autologous) stem cells extracted from your bone marrow.”

    Sorry, in progress, not accepting new patients

    This pilot study is to determine whether it would be safe and feasible to inject CD34+ stem cells from bone marrow into the eye as treatment for patients who are irreversibly blind from various retinal conditions.

    at UC Davis

Our lead scientists for Retinal Vein Occlusion research studies include .

Last updated: